Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Reed

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerP M Quilty, D Kirk, J J Bolger, et al.
Seminars in Oncology|June 1, 1993
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators GroupJ J Bolger, D P Dearnaley, D Kirk, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 4, 1998
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma GroupD J Dunlop, M M Eatock, J Paul, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working PartyF R Macbeth, T E Wheldon, D J Girling, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancerP A Vasey, R Atkinson, R Osborne, et al.
British Journal of Cancer|February 13, 2001
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancerP A Vasey, R Atkinson, R Coleman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancerR P Symonds, T Habeshaw, N S Reed, et al.
British Journal of Cancer|July 4, 1998
Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalationM J Mackean, J Cassidy, D I Jodrell, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancerM Zweifel, G C Jayson, N S Reed, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerP M Quilty, D Kirk, J J Bolger, et al.
Seminars in Oncology|June 1, 1993
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators GroupJ J Bolger, D P Dearnaley, D Kirk, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 4, 1998
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma GroupD J Dunlop, M M Eatock, J Paul, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working PartyF R Macbeth, T E Wheldon, D J Girling, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancerP A Vasey, R Atkinson, R Osborne, et al.
British Journal of Cancer|February 13, 2001
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancerP A Vasey, R Atkinson, R Coleman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancerR P Symonds, T Habeshaw, N S Reed, et al.
British Journal of Cancer|July 4, 1998
Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalationM J Mackean, J Cassidy, D I Jodrell, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancerM Zweifel, G C Jayson, N S Reed, et al.
Pageof 5